Cantor Fitzgerald, Morgan Stanley, and Royal Bank of Canada issued price target updates for Elevance Health, Inc. on September 12, 2026.
1 report, 1 independent
Updated Sep 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald, Morgan Stanley, and Royal Bank of Canada issued price target updates for Elevance Health, Inc. on September 12, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Elevance Health, Inc.
American healthcare company
Nothing else this week.
-
Cantor Fitzgerald
American financial services company
-
Morgan Stanley
U.S. investment bank
Related events
- Cantor Fitzgerald restated an overweight rating and Royal Bank of Canada reduced its price objective for United Therapeutics.
- Cantor Fitzgerald began coverage and issued rating, and Morgan Stanley upgraded price objective and rating for Silence Therapeutics.
- Cantor Fitzgerald and Royal Bank of Canada updated their ratings and positions regarding Rezolve Ai.
- Cantor Fitzgerald decreased its price target on BigBear.ai on September 13, 2026.
- Cantor Fitzgerald raised price targets and reaffirmed ratings, while TD Cowen adjusted its ratings for Paylocity on August 7, 2026.